Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

First in-human trials of rovalpituzumab for SCLC

Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA
First in-human trials of rovalpituzumab for SCLC ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Jun 2016

ASCO 2016: Plenary Session Review

Dr Julie Vose - President of ASCO
ASCO 2016: Plenary Session Review ( Dr Julie Vose - President of ASCO )
5 Jun 2016

Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery

Prof John Neoptolemos - University of Liverpool, Liverpool, UK
Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery ( Prof John Neoptolemos - University of Liverpool, Liverpool, UK )
5 Jun 2016

Latest in hepatocellular carcinoma treatments

Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
Latest in hepatocellular carcinoma treatments ( Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2016

Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin

Dr Hope Rugo - University of California, San Francisco, USA
Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )
3 Jun 2016

Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin

Dr Hope Rugo - University of California, San Francisco, USA
Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )
3 Jun 2016

Mechanistic studies of DNA repair

Tomas Lindahl - Nobel Prize for Chemistry 2015
Mechanistic studies of DNA repair ( Tomas Lindahl - Nobel Prize for Chemistry 2015 )
13 May 2016

Use of novel agents in childhood ALL

Prof Lia Gore - Children's Hospital Colarado, Aurora, USA
Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )
6 May 2016

Relapsed Hodgkin lymphoma in PET positive patients

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016

First outcome results from MINDACT breast cancer clinical trial

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium
First outcome results from MINDACT breast cancer clinical trial ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
6 May 2016

A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA
A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )
6 May 2016

5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
6 May 2016